Relationship between exercise-induced myocardial ischemia and reduced left ventricular distensibility in patients with nonobstructive hypertrophic cardiomyopathy

Journal of Nuclear Medicine

Volumn 44, Issue 11, 2003, Pages 1717-1724

  Isobe, Satoshi ^a   Izawa, Hideo ^a   Takeichi, Yasushi ^a   Nonokawa, Makoto ^a   Nanasato, Mamoru ^a   Ando, Akitada ^a   Kato, Katsuhiko ^b   Ikeda, Mitsuru ^b   Murohara, Toyoaki ^a   Yokota, Mitsuhiro ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

201TI scintigraphy; Hypertrophic cardiomyopathy; Left ventricular distensibility; Myocardial ischemia

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; THALLIUM;

ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; LUNG WEDGE PRESSURE; PRIORITY JOURNAL; REDUCTION; STRESS; ADULT; AGED; DIASTOLE; FEMALE; HEART; HEART LEFT VENTRICLE FUNCTION; HYPERTROPHIC CARDIOMYOPATHY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; DIASTOLE; EXERCISE; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 10844225441     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kawai C, Takatsu T. Clinical and experimental studies on cardiomyopathy N Eng J Med. 1975;293:592-597.
2. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy (1). N Eng J Med. 1987;316:780-789.
3. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE. Hypertrophic cardiomyopathy interrelations of clinical manifestations, pathophysiology, and therapy (2). N Eng J Med. 1987;316:844-852.
4. Stewart S, Mason DT, Brawnwald E. Impaired rate of left ventricular filling in idiopathic hypertrophic subaortic stenosis and valvular aortic stenosis Circulation. 1968;37:8-14.
5. Moreyra E, Klein JJ, Shimada H, Segal BL. Idiopathic hypertrophic subaortic stenosis diagnosed by reflected ultrasound. Am J Cardiol 1969;23:32-37.
6. St John Sutton MG, Tajik AJ, Gibson DG, Brown DJ, Seward JB, Giuliam ER. Echocardiographic assessment of left ventricular filling and septal and posterior wall dynamics in idiopathic hypertrophic subaortic stenosis. Circulation. 1978;57:512-520.
7. Hanrath P, Mathey DG, Siegert R, Bleifeld W Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy. an echocardiographic study. Am J Cardiol. 1980;45:15-23
8. Bonow RO, Rosing DR, Bacharach SL, et al Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation. 1981;64:787-796.
9. Pak PH, Maughan WL, Baughman KL, Kass DA. Marked discordance between dynamic and passive diastolic pressure-volume relations in idiopathic hypertrophic cardiomyopathy. Circulation. 1996;94:52-60.
10. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986;8:545-557.
11. Cannon RO III, Dilsizian V, O'Gara PT, et al Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation. 1991;83:1660-1667.
12. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1993;22:796-804.
13. Cannon RO III, Rosing DR, Maron BJ, et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy. contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation. 1985;71:234-243
14. O'Gara PT, Bonow RO, Maron BJ, et al Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography Circulation. 1987;76:1214-1223.
15. Pichard AD, Meller J, Teichholz LE, Lipnik S, Gorlin R, Herman MV. Septal perforator compression (narrowing) in idiopathic hypertrophic subaortic stenosis Am Heart J. 1977;40:310-314
16. Thompson DS, Naqvi N, Juul SM, et al Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy. Br Heart J. 1980;44:488-498
17. Ikeda H, Shimamatsu M, Yoshiga O, Shibao K, Koga Y, Toshima H Impaired myocardial perfusion in patients with hypertrophic cardiomyopathy: assessment with digital subtraction coronary arteriography. Heart Vessels. 1998;4:170-178.
18. Bonow RO, Dilsizian V, Rosing DR, Maron BJ, Bacharach SL, Green MV. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy short- and long-term effects. Circulation 1985;72:853-864.
19. Opherk D, Mall G, Zebe H, et al. Reduction of coronary reserve, a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation. 1984;69:1-7
20. St John Sutton MG, Lie JT, Anderson KR, O'Brien PC, Frye RL. Histopathological specificity of hypertrophic obstructive cardiomyopathy: myocardial fibre disarray and myocardial fibrosis Br Heart J. 1980;44:433-443.
21. Izawa H, Yokota M, Takeichi Y, et al. Adrenergic control of the force-frequency and relaxation-frequency relations in patients with hypertrophic cardiomyopathy. Circulation. 1997;96:2959-2968.
22. Takeichi Y, Yokota M, Iwase M, et al Biphasic changes in left ventricular end-diastolic pressure during dynamic exercise in patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2001;38:335-343.
23. Richardson P, McKenna WJ, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 1996;93:841-842
24. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy, proposal for new diagnostic criteria in adult members of affected families. Heart. 1997;77:130-132
25. Berman DS, Hachamovitch R, Kiat H, et al Incremental vale of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639-647.
26. Bacher-Stier C, Müller S, Pachinger O, et al. Thallium-201 gated single-photon emission tomography for the assessment of left ventricular ejection fraction and regional wall motion abnormalities in comparison with two-dimensional echocardiography. Eur J Nucl Med. 1999;26:1533-1540.
27. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
28. Gambhir SS, Schwaiger M, Huang SC, et al Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med. 1989; 30:359-366.
29. Gaasch WH, Levine HJ, Quinones MA, Alexander JK. Left ventricular compliance: mechanisms and clinical implications. Am J Cardiol. 1976;38:645-653.
30. Grossman W, McLaurin LP. Diastolic properties of the left ventricle. Ann Intern Med. 1976;84:316-326.
31. Sanderson JE, Gibson DG, Brown DJ, Goodwin JF. Left ventricular filling in hypertrophic cardiomyopathy: an angiographic study. Br Heart J. 1977;39:661-670.
32. Losi MA, Betocchi S, Manganelli F, et al. Pattern of left ventricular filling in hypertrophic cardiomyopathy: assessment by Doppler echocardiography and radionuclide angiography. Eur Heart J. 1998;19:1261-1267.
33. Ferrans VJ, Morrow AG, Roberts WC. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis: a study of operatively excised left ventricular outflow tract muscle in 14 patients Circulation 1972;45:769-792
34. Camici P, Chiriatti G, Lorenzoni R, et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy, a study with nitrogen-13 ammonia and positron emission tomography J Am Coll Cardiol. 1991;17:879-886.
35. Ohtsuki K, Sugihara H, Kuribayashi T, Nakagawa M Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. J Nucl Med. 1999;40:2007-2013.
36. Hirasaki S, Nakamura T, Kuribayashi T, et al. Abnormal course, abnormal flow, and systolic compression of the septal perforator associated with impaired myocardial perfusion in hypertrophic cardiomyopathy. Am Heart J. 1999;137:109-117.
37. Kunbayashi T, Roberts WC. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol. 1992;70:1333-1340
38. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients Circulation. 1982;65:1388-1394.
39. Elliott PM, Poloniecki J, Dickie S, et al. Sudden death in hypertrophic cardiomyopathy, identification of high risk patients. J Am Coll Cardiol 2000;36:2212-2218.
40. Matsushita T, Tanaka Y, Horinouchi O, Sonoda M, Arima T. Heart rate decline after exercise in patients with hypertrophic cardiomyopathy J Electrocardiol 2001;34:141-146.